Report Detail

Pharma & Healthcare Global Corticosteroid Injections for Joint Pain Market Growth 2019-2024

  • RnM3206331
  • |
  • 28 March, 2019
  • |
  • Global
  • |
  • 130 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Corticosteroid Injections products used for Joint Pain.

According to this study, over the next five years the Corticosteroid Injections for Joint Pain market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Corticosteroid Injections for Joint Pain business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroid Injections for Joint Pain market by product type, application, key manufacturers and key regions and countries.

This study considers the Corticosteroid Injections for Joint Pain value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Corticosteroid Injections for Joint Pain consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Corticosteroid Injections for Joint Pain market by identifying its various subsegments.
Focuses on the key global Corticosteroid Injections for Joint Pain manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Corticosteroid Injections for Joint Pain with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Corticosteroid Injections for Joint Pain submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Corticosteroid Injections for Joint Pain Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Corticosteroid Injections for Joint Pain Consumption 2014-2024
        • 2.1.2 Corticosteroid Injections for Joint Pain Consumption CAGR by Region
      • 2.2 Corticosteroid Injections for Joint Pain Segment by Type
        • 2.2.1 Knee & Ankle
        • 2.2.2 Hip Joint
        • 2.2.3 Shoulder & Elbow
        • 2.2.4 Facet Joints of the Spine
        • 2.2.5 Others
      • 2.3 Corticosteroid Injections for Joint Pain Consumption by Type
        • 2.3.1 Global Corticosteroid Injections for Joint Pain Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Corticosteroid Injections for Joint Pain Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Type (2014-2019)
      • 2.4 Corticosteroid Injections for Joint Pain Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Retail Pharmacies
        • 2.4.3 Online Pharmacies
      • 2.5 Corticosteroid Injections for Joint Pain Consumption by Application
        • 2.5.1 Global Corticosteroid Injections for Joint Pain Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Corticosteroid Injections for Joint Pain Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Corticosteroid Injections for Joint Pain Sale Price by Application (2014-2019)

      3 Global Corticosteroid Injections for Joint Pain by Players

      • 3.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Players
        • 3.1.1 Global Corticosteroid Injections for Joint Pain Sales by Players (2017-2019)
        • 3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Players (2017-2019)
      • 3.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Players
        • 3.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Players (2017-2019)
        • 3.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Players (2017-2019)
      • 3.3 Global Corticosteroid Injections for Joint Pain Sale Price by Players
      • 3.4 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Corticosteroid Injections for Joint Pain Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Corticosteroid Injections for Joint Pain Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Corticosteroid Injections for Joint Pain by Regions

      • 4.1 Corticosteroid Injections for Joint Pain by Regions
        • 4.1.1 Global Corticosteroid Injections for Joint Pain Consumption by Regions
        • 4.1.2 Global Corticosteroid Injections for Joint Pain Value by Regions
      • 4.2 Americas Corticosteroid Injections for Joint Pain Consumption Growth
      • 4.3 APAC Corticosteroid Injections for Joint Pain Consumption Growth
      • 4.4 Europe Corticosteroid Injections for Joint Pain Consumption Growth
      • 4.5 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption Growth

      5 Americas

      • 5.1 Americas Corticosteroid Injections for Joint Pain Consumption by Countries
        • 5.1.1 Americas Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
        • 5.1.2 Americas Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
      • 5.2 Americas Corticosteroid Injections for Joint Pain Consumption by Type
      • 5.3 Americas Corticosteroid Injections for Joint Pain Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Corticosteroid Injections for Joint Pain Consumption by Countries
        • 6.1.1 APAC Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
        • 6.1.2 APAC Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
      • 6.2 APAC Corticosteroid Injections for Joint Pain Consumption by Type
      • 6.3 APAC Corticosteroid Injections for Joint Pain Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Corticosteroid Injections for Joint Pain by Countries
        • 7.1.1 Europe Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
        • 7.1.2 Europe Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
      • 7.2 Europe Corticosteroid Injections for Joint Pain Consumption by Type
      • 7.3 Europe Corticosteroid Injections for Joint Pain Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Corticosteroid Injections for Joint Pain by Countries
        • 8.1.1 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Corticosteroid Injections for Joint Pain Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Type
      • 8.3 Middle East & Africa Corticosteroid Injections for Joint Pain Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Corticosteroid Injections for Joint Pain Distributors
      • 10.3 Corticosteroid Injections for Joint Pain Customer

      11 Global Corticosteroid Injections for Joint Pain Market Forecast

      • 11.1 Global Corticosteroid Injections for Joint Pain Consumption Forecast (2019-2024)
      • 11.2 Global Corticosteroid Injections for Joint Pain Forecast by Regions
        • 11.2.1 Global Corticosteroid Injections for Joint Pain Forecast by Regions (2019-2024)
        • 11.2.2 Global Corticosteroid Injections for Joint Pain Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Corticosteroid Injections for Joint Pain Forecast by Type
      • 11.8 Global Corticosteroid Injections for Joint Pain Forecast by Application

      12 Key Players Analysis

      • 12.1 Allergan
        • 12.1.1 Company Details
        • 12.1.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Allergan News
      • 12.2 Pfizer
        • 12.2.1 Company Details
        • 12.2.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Pfizer News
      • 12.3 Sanofi
        • 12.3.1 Company Details
        • 12.3.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sanofi News
      • 12.4 Anika Therapeutics
        • 12.4.1 Company Details
        • 12.4.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Anika Therapeutics News
      • 12.5 Ferring
        • 12.5.1 Company Details
        • 12.5.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Ferring News
      • 12.6 Bioventus
        • 12.6.1 Company Details
        • 12.6.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Bioventus News
      • 12.7 Flexion Therapeutics
        • 12.7.1 Company Details
        • 12.7.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Flexion Therapeutics News
      • 12.8 Zimmer Biomet
        • 12.8.1 Company Details
        • 12.8.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Zimmer Biomet News
      • 12.9 SEIKAGAKU
        • 12.9.1 Company Details
        • 12.9.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 SEIKAGAKU News
      • 12.10 Chugai Pharma
        • 12.10.1 Company Details
        • 12.10.2 Corticosteroid Injections for Joint Pain Product Offered
        • 12.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Chugai Pharma News

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Corticosteroid Injections for Joint Pain. Industry analysis & Market Report on Corticosteroid Injections for Joint Pain is a syndicated market report, published as Global Corticosteroid Injections for Joint Pain Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Corticosteroid Injections for Joint Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,928.00
      4,392.00
      5,856.00
      3,517.26
      5,275.89
      7,034.52
      558,589.20
      837,883.80
      1,117,178.40
      319,847.40
      479,771.10
      639,694.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report